"10.1371_journal.pone.0038744","plos one","2012-06-22T00:00:00Z","Matthias Kern; Nora Klöting; Heiko G Niessen; Leo Thomas; Detlef Stiller; Michael Mark; Thomas Klein; Matthias Blüher","Department of Medicine, University of Leipzig, Leipzig, Germany; IFB Obesity Diseases, Junior Research Group Animal Models, University of Leipzig, Leipzig, Germany; Boehringer-Ingelheim Pharma GmbH & Co. KG, Biberach, Germany","Conceived and designed the experiments: MK NK MB. Performed the experiments: MK NK HGN LT MM DS MB. Analyzed the data: MK NK TK MB. Contributed reagents/materials/analysis tools: HGN LT DS MM TK. Wrote the paper: MK NK TK MB.","L. Thomas, H. G. Niessen, D. Stiller, T. Klein, and M. Mark are employees of Boehringer Ingelheim Pharma. Linagliptin is a Boehringer Ingelheim Pharma product. There are no other patents, products in development or other marketed products to declare. This does not alter the authors’ adherence to all the PLoS ONE policies on sharing data and materials.","2012","06","Matthias Kern","MK",8,TRUE,3,7,4,4,TRUE,TRUE,FALSE,0,NA,FALSE
